$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | JAZZ | Jazz Pharmaceutica ... | Tovey Christopher J. | EVP COO & Managing ... | Grant | A | 0.00 | 9,091 | 0 | 9,116 | 25 to 9.1 K (+36,364.00 %) |
May 07 2021 | JAZZ | Jazz Pharmaceutica ... | Tovey Christopher J. | EVP COO & Managing ... | Grant | A | 0.00 | 9,091 | 0 | 9,116 | 25 to 9.1 K (+36,364.00 %) |
May 05 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 170.00 | 500 | 85,000 | 321,341 | 321.8 K to 321.3 K (-0.16 %) |
May 05 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 164.24 | 1,500 | 246,360 | 321,841 | 323.3 K to 321.8 K (-0.46 %) |
Apr 07 2021 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Payment of Exercise | F | 164.71 | 1,515 | 249,536 | 25,347 | 26.9 K to 25.3 K (-5.64 %) |
Apr 06 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 164.96 | 1,500 | 247,440 | 323,341 | 324.8 K to 323.3 K (-0.46 %) |
Mar 10 2021 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Sell | S | 161.60 | 1,509 | 243,859 | 16,519 | 18 K to 16.5 K (-8.37 %) |
Mar 10 2021 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 161.50 | 961 | 155,202 | 6,045 | 7 K to 6 K (-13.72 %) |
Mar 10 2021 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 161.61 | 1,089 | 175,988 | 7,006 | 8.1 K to 7 K (-13.45 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Payment of Exercise | F | 164.75 | 3,718 | 612,541 | 49,961 | 53.7 K to 50 K (-6.93 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Pearce Samantha | SVP, Head of Europ ... | Payment of Exercise | F | 164.75 | 1,402 | 230,980 | 11,958 | 13.4 K to 12 K (-10.49 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Payment of Exercise | F | 164.75 | 691 | 113,842 | 26,147 | 26.8 K to 26.1 K (-2.57 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP R&D, Chief Medi ... | Payment of Exercise | F | 164.75 | 741 | 122,080 | 30,145 | 30.9 K to 30.1 K (-2.40 %) |
Mar 09 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 164.75 | 21,516 | 3,544,761 | 324,841 | 346.4 K to 324.8 K (-6.21 %) |
Mar 03 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 170.00 | 9,600 | 1,632,000 | 346,357 | 356 K to 346.4 K (-2.70 %) |
Mar 01 2021 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Grant | A | 0.00 | 10,115 | 0 | 26,862 | 16.7 K to 26.9 K (+60.40 %) |
Mar 01 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Grant | A | 0.00 | 37,925 | 0 | 355,957 | 318 K to 356 K (+11.92 %) |
Mar 01 2021 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Grant | A | 0.00 | 1,895 | 0 | 8,095 | 6.2 K to 8.1 K (+30.56 %) |
Mar 01 2021 | JAZZ | Jazz Pharmaceutica ... | Smith Mark Douglas | Director | Option Exercise | A | 170.74 | 6,475 | 1,105,542 | 6,475 | |
Mar 01 2021 | JAZZ | Jazz Pharmaceutica ... | Smith Mark Douglas | Director | Grant | A | 0.00 | 2,590 | 0 | 2,590 | 0 to 2.6 K |
Mar 01 2021 | JAZZ | Jazz Pharmaceutica ... | Cook Jennifer E. | Director | Option Exercise | A | 170.74 | 6,475 | 1,105,542 | 6,475 | |
Mar 01 2021 | JAZZ | Jazz Pharmaceutica ... | Cook Jennifer E. | Director | Grant | A | 0.00 | 2,590 | 0 | 2,590 | 0 to 2.6 K |
Jan 06 2021 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 162.01 | 7,950 | 1,287,980 | 319,532 | 327.5 K to 319.5 K (-2.43 %) |
Jan 06 2021 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Payment of Exercise | F | 160.40 | 1,607 | 257,763 | 41,984 | 43.6 K to 42 K (-3.69 %) |
Dec 08 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 152.55 | 62 | 9,458 | 6,200 | 6.3 K to 6.2 K (-0.99 %) |
Dec 03 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.00 | 250 | 37,500 | 327,482 | 327.7 K to 327.5 K (-0.08 %) |
Dec 03 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 140.58 | 1,000 | 140,580 | 327,732 | 328.7 K to 327.7 K (-0.30 %) |
Nov 13 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.61 | 1,623 | 239,575 | 20,368 | 22 K to 20.4 K (-7.38 %) |
Nov 13 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 147.00 | 5,083 | 747,217 | 21,991 | 27.1 K to 22 K (-18.77 %) |
Nov 13 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 145.81 | 3,223 | 469,946 | 27,074 | 30.3 K to 27.1 K (-10.64 %) |
Nov 10 2020 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Sell | S | 151.93 | 197 | 29,930 | 13,964 | 14.2 K to 14 K (-1.39 %) |
Nov 09 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 156.44 | 4,513 | 706,003 | 18,667 | 23.2 K to 18.7 K (-19.47 %) |
Nov 09 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 155.14 | 1,746 | 270,867 | 23,180 | 24.9 K to 23.2 K (-7.00 %) |
Nov 09 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 153.74 | 2,740 | 421,255 | 24,926 | 27.7 K to 24.9 K (-9.90 %) |
Nov 09 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 152.57 | 2,001 | 305,295 | 27,666 | 29.7 K to 27.7 K (-6.74 %) |
Nov 09 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 156.44 | 4,513 | 706,003 | 18,667 | 23.2 K to 18.7 K (-19.47 %) |
Nov 09 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 155.14 | 1,746 | 270,867 | 23,180 | 24.9 K to 23.2 K (-7.00 %) |
Nov 09 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 153.74 | 2,740 | 421,255 | 24,926 | 27.7 K to 24.9 K (-9.90 %) |
Nov 09 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 152.57 | 2,001 | 305,295 | 27,666 | 29.7 K to 27.7 K (-6.74 %) |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 46.83 | 8,000 | 374,640 | 0 | |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 152.00 | 8,000 | 1,216,000 | 10,622 | 18.6 K to 10.6 K (-42.96 %) |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Buy | M | 46.83 | 8,000 | 374,640 | 18,622 | 10.6 K to 18.6 K (+75.32 %) |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 156.00 | 4,500 | 702,000 | 10,622 | 15.1 K to 10.6 K (-29.76 %) |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Buy | M | 81.76 | 4,500 | 367,920 | 15,122 | 10.6 K to 15.1 K (+42.36 %) |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 81.76 | 4,500 | 367,920 | 0 | |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | M | 46.83 | 8,000 | 374,640 | 0 | |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 152.00 | 8,000 | 1,216,000 | 10,622 | 18.6 K to 10.6 K (-42.96 %) |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Buy | M | 46.83 | 8,000 | 374,640 | 18,622 | 10.6 K to 18.6 K (+75.32 %) |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 156.00 | 4,500 | 702,000 | 10,622 | 15.1 K to 10.6 K (-29.76 %) |
Nov 06 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Buy | M | 81.76 | 4,500 | 367,920 | 15,122 | 10.6 K to 15.1 K (+42.36 %) |
Nov 04 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | M | 0.00 | 22,249 | 0 | 0 | |
Nov 04 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Buy | M | 0.00 | 22,249 | 0 | 29,667 | 7.4 K to 29.7 K (+299.93 %) |
Sep 10 2020 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Sell | S | 138.53 | 63 | 8,727 | 14,161 | 14.2 K to 14.2 K (-0.44 %) |
Sep 03 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 134.90 | 500 | 67,450 | 336,680 | 337.2 K to 336.7 K (-0.15 %) |
Sep 03 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 134.90 | 500 | 67,450 | 336,680 | 337.2 K to 336.7 K (-0.15 %) |
Aug 31 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 130.00 | 3,000 | 390,000 | 337,180 | 340.2 K to 337.2 K (-0.88 %) |
Aug 14 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 123.80 | 142 | 17,580 | 6,200 | 6.3 K to 6.2 K (-2.24 %) |
Aug 11 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 125.87 | 158 | 19,887 | 6,342 | 6.5 K to 6.3 K (-2.43 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | ORiordan Anne | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | ORiordan Anne | Director | Grant | A | 0.00 | 2,705 | 0 | 7,465 | 4.8 K to 7.5 K (+56.83 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | S | 125.87 | 931 | 117,185 | 6,198 | 7.1 K to 6.2 K (-13.06 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 2,705 | 0 | 7,129 | 4.4 K to 7.1 K (+61.14 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Sell | S | 125.87 | 931 | 117,186 | 10,622 | 11.6 K to 10.6 K (-8.06 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 2,705 | 0 | 11,553 | 8.8 K to 11.6 K (+30.57 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Schnee Elmar | Director | Grant | A | 0.00 | 2,705 | 0 | 9,902 | 7.2 K to 9.9 K (+37.59 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Sell | S | 125.87 | 931 | 117,186 | 9,459 | 10.4 K to 9.5 K (-8.96 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | RIEDEL NORBERT G | Director | Grant | A | 0.00 | 2,705 | 0 | 10,390 | 7.7 K to 10.4 K (+35.20 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 125.87 | 931 | 117,186 | 7,418 | 8.3 K to 7.4 K (-11.15 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 2,705 | 0 | 8,349 | 5.6 K to 8.3 K (+47.93 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 2,705 | 0 | 1,155,493 | 1.2 M to 1.2 M (+0.23 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Sell | S | 125.87 | 1,009 | 127,003 | 10,333 | 11.3 K to 10.3 K (-8.90 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | McSharry Heather Ann | Director | Grant | A | 0.00 | 2,705 | 0 | 11,342 | 8.6 K to 11.3 K (+31.32 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | Gray Peter | Director | Grant | A | 0.00 | 2,705 | 0 | 12,020 | 9.3 K to 12 K (+29.04 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 2,705 | 0 | 20,368 | 17.7 K to 20.4 K (+15.31 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 127.07 | 6,765 | 859,629 | 6,765 | |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 125.87 | 931 | 117,185 | 9,740 | 10.7 K to 9.7 K (-8.72 %) |
Aug 10 2020 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 2,705 | 0 | 10,671 | 8 K to 10.7 K (+33.96 %) |
Aug 07 2020 | JAZZ | Jazz Pharmaceutica ... | Sablich Kim | EVP & GM, North Ame ... | Option Exercise | A | 127.07 | 38,856 | 4,937,432 | 38,856 | |
Aug 07 2020 | JAZZ | Jazz Pharmaceutica ... | Sablich Kim | EVP & GM, North Ame ... | Option Exercise | A | 127.07 | 3,144 | 399,508 | 3,144 | |
Aug 07 2020 | JAZZ | Jazz Pharmaceutica ... | Sablich Kim | EVP & GM, North Ame ... | Grant | A | 0.00 | 16,800 | 0 | 16,800 | 0 to 16.8 K |
Aug 07 2020 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Payment of Exercise | F | 122.24 | 987 | 120,651 | 19,489 | 20.5 K to 19.5 K (-4.82 %) |
Jun 05 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Payment of Exercise | F | 120.65 | 943 | 113,773 | 22,204 | 23.1 K to 22.2 K (-4.07 %) |
Jun 05 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Payment of Exercise | F | 120.65 | 943 | 113,773 | 22,204 | 23.1 K to 22.2 K (-4.07 %) |
Jun 05 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 124.00 | 138 | 17,112 | 6,500 | 6.6 K to 6.5 K (-2.08 %) |
Jun 05 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 124.00 | 138 | 17,112 | 6,500 | 6.6 K to 6.5 K (-2.08 %) |
May 27 2020 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 112.32 | 11,482 | 1,289,646 | 1,152,788 | 1.1 M to 1.2 M (+1.01 %) |
May 27 2020 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 111.56 | 9,884 | 1,102,682 | 1,141,306 | 1.1 M to 1.1 M (+0.87 %) |
May 27 2020 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 110.52 | 8,391 | 927,352 | 1,131,422 | 1.1 M to 1.1 M (+0.75 %) |
May 27 2020 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 109.55 | 5,243 | 574,379 | 1,123,031 | 1.1 M to 1.1 M (+0.47 %) |
May 27 2020 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Buy | P | 110.65 | 15,000 | 1,659,747 | 1,117,788 | 1.1 M to 1.1 M (+1.36 %) |
May 11 2020 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Option Exercise | A | 109.45 | 37,848 | 4,142,464 | 37,848 | |
May 11 2020 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Option Exercise | A | 109.45 | 3,652 | 399,711 | 3,652 | |
May 11 2020 | JAZZ | Jazz Pharmaceutica ... | GALA RENEE D | EVP & CFO | Grant | A | 0.00 | 16,600 | 0 | 16,600 | 0 to 16.6 K |
May 11 2020 | JAZZ | Jazz Pharmaceutica ... | Pearce Samantha | SVP, Europe and Res ... | Option Exercise | A | 109.45 | 25,500 | 2,790,975 | 25,500 | |
May 11 2020 | JAZZ | Jazz Pharmaceutica ... | Pearce Samantha | SVP, Europe and Res ... | Grant | A | 0.00 | 10,200 | 0 | 10,200 | 0 to 10.2 K |
Mar 13 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 102.17 | 600 | 61,302 | 6,500 | 7.1 K to 6.5 K (-8.45 %) |
Mar 13 2020 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 102.17 | 1,500 | 153,255 | 22,118 | 23.6 K to 22.1 K (-6.35 %) |
Mar 10 2020 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Sell | S | 111.49 | 615 | 68,566 | 13,883 | 14.5 K to 13.9 K (-4.24 %) |
Mar 10 2020 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Sell | S | 119.15 | 292 | 34,793 | 14,498 | 14.8 K to 14.5 K (-1.97 %) |
Mar 10 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 111.45 | 568 | 63,303 | 7,100 | 7.7 K to 7.1 K (-7.41 %) |
Mar 10 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 119.17 | 232 | 27,648 | 7,668 | 7.9 K to 7.7 K (-2.94 %) |
Mar 09 2020 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Payment of Exercise | F | 124.50 | 1,735 | 216,008 | 43,391 | 45.1 K to 43.4 K (-3.84 %) |
Mar 09 2020 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Payment of Exercise | F | 124.50 | 2,423 | 301,664 | 23,618 | 26 K to 23.6 K (-9.30 %) |
Mar 09 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 124.50 | 15,071 | 1,876,340 | 340,033 | 355.1 K to 340 K (-4.24 %) |
Mar 05 2020 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Sell | S | 119.75 | 279 | 33,410 | 14,790 | 15.1 K to 14.8 K (-1.85 %) |
Mar 05 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 118.67 | 253 | 30,024 | 7,900 | 8.2 K to 7.9 K (-3.10 %) |
Mar 05 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 119.75 | 247 | 29,578 | 8,153 | 8.4 K to 8.2 K (-2.94 %) |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Option Exercise | A | 113.10 | 39,114 | 4,423,793 | 39,114 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Option Exercise | A | 113.10 | 886 | 100,207 | 886 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Grant | A | 0.00 | 16,000 | 0 | 45,126 | 29.1 K to 45.1 K (+54.93 %) |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Option Exercise | A | 113.10 | 20,125 | 2,276,138 | 20,125 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Option Exercise | A | 113.10 | 875 | 98,963 | 875 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Patil Neena M | SVP, General Counse ... | Grant | A | 0.00 | 8,400 | 0 | 20,400 | 12 K to 20.4 K (+70.00 %) |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Option Exercise | A | 113.10 | 12,500 | 1,413,750 | 12,500 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Grant | A | 0.00 | 5,000 | 0 | 15,069 | 10.1 K to 15.1 K (+49.66 %) |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Option Exercise | A | 113.10 | 26,116 | 2,953,720 | 26,116 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Option Exercise | A | 113.10 | 884 | 99,980 | 884 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Iannone Robert | EVP, Research & Dev ... | Grant | A | 0.00 | 10,800 | 0 | 23,000 | 12.2 K to 23 K (+88.52 %) |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 113.10 | 129,115 | 14,602,907 | 129,115 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | A | 113.10 | 885 | 100,094 | 885 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Grant | A | 0.00 | 52,000 | 0 | 355,104 | 303.1 K to 355.1 K (+17.16 %) |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Option Exercise | A | 113.10 | 6,500 | 735,150 | 6,500 | |
Mar 02 2020 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Grant | A | 0.00 | 2,600 | 0 | 8,400 | 5.8 K to 8.4 K (+44.83 %) |
Feb 26 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Option Exercise | M | 11.48 | 6,895 | 79,155 | 0 | |
Feb 26 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Payment of Exercise | F | 127.25 | 2,679 | 340,903 | 303,104 | 305.8 K to 303.1 K (-0.88 %) |
Feb 26 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Buy | M | 11.48 | 6,895 | 79,155 | 305,783 | 298.9 K to 305.8 K (+2.31 %) |
Feb 14 2020 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 142.18 | 1,500 | 213,270 | 26,571 | 28.1 K to 26.6 K (-5.34 %) |
Feb 05 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 143.83 | 1,000 | 143,830 | 298,888 | 299.9 K to 298.9 K (-0.33 %) |
Jan 15 2020 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 146.78 | 1,500 | 220,170 | 28,071 | 29.6 K to 28.1 K (-5.07 %) |
Jan 06 2020 | JAZZ | Jazz Pharmaceutica ... | Swisher Daniel N JR | President and COO | Sell | D | 146.09 | 1,599 | 233,598 | 29,126 | 30.7 K to 29.1 K (-5.20 %) |
Jan 06 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.00 | 250 | 37,500 | 299,888 | 300.1 K to 299.9 K (-0.08 %) |
Jan 06 2020 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 149.51 | 1,000 | 149,510 | 300,138 | 301.1 K to 300.1 K (-0.33 %) |
Dec 10 2019 | JAZZ | Jazz Pharmaceutica ... | MILLER MICHAEL PATRICK | EVP, US Commercial | Sell | S | 149.12 | 1,500 | 223,680 | 29,571 | 31.1 K to 29.6 K (-4.83 %) |
Dec 09 2019 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Option Exercise | M | 123.36 | 1,667 | 205,641 | 313 | |
Dec 09 2019 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 149.84 | 82 | 12,287 | 5,800 | 5.9 K to 5.8 K (-1.39 %) |
Dec 09 2019 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Sell | S | 148.89 | 1,667 | 248,198 | 5,882 | 7.5 K to 5.9 K (-22.08 %) |
Dec 09 2019 | JAZZ | Jazz Pharmaceutica ... | Carr Patricia | VP, Finance & PAO | Buy | M | 123.36 | 1,667 | 205,641 | 7,549 | 5.9 K to 7.5 K (+28.34 %) |
Dec 06 2019 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 147.82 | 6,750 | 997,774 | 4,445 | 11.2 K to 4.4 K (-60.29 %) |
Dec 04 2019 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman & CEO | Sell | S | 150.00 | 10,750 | 1,612,500 | 301,138 | 311.9 K to 301.1 K (-3.45 %) |
Nov 08 2019 | JAZZ | Jazz Pharmaceutica ... | Larkin Finbar | SVP, Technical Oper ... | Grant | A | 0.00 | 1,500 | 0 | 9,988 | 8.5 K to 10 K (+17.67 %) |